JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online July 16, 2008, 10.2967/jnumed.108.050849
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.108.050849v1
49/8/1257    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schreckenberger, M.
Right arrow Articles by Bartenstein, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schreckenberger, M.
Right arrow Articles by Bartenstein, P.
Journal of Nuclear Medicine Vol. 49 No. 8 1257-1261
© 2008 by Society of Nuclear Medicine

doi: 10.2967/jnumed.108.050849

Clinical Investigation

Opioid Receptor PET Reveals the Psychobiologic Correlates of Reward Processing

Mathias Schreckenberger1, André Klega1, Gerhard Gründer2,3, Hans-Georg Buchholz1, Armin Scheurich2, Ralf Schirrmacher1,4, Esther Schirrmacher1,4, Christina Müller1, Gjermund Henriksen5 and Peter Bartenstein1,6

1 Department of Nuclear Medicine, Johannes Gutenberg-University, Mainz, Germany; 2 Department of Psychiatry and Psychotherapy, Johannes Gutenberg-University, Mainz, Germany; 3 Department of Psychiatry and Psychotherapy, Aachen University of Technology, Aachen, Germany; 4 Department of Neurology and Neurosurgery, McGill University, Montreal, Canada; 5 Department of Nuclear Medicine, Technical University, Munich, Germany; and 6 Department of Nuclear Medicine, Ludwig Maximilians-University, Munich, Germany

Correspondence: For correspondence or reprints contact: Mathias Schreckenberger, Department of Nuclear Medicine, University of Mainz, Langenbeckstrasse 1, D-55101 Mainz, Germany. E-mail: schreckenberger{at}nuklear.klinik.uni-mainz.de

Little is known about the neurobiologic correlates of human personality. On the basis of the key role of the central opioidergic system in addiction and substance abuse, we investigated the relationship between certain personality traits that are supposed to be relevant in addiction and the opioid receptor status in healthy subjects. Methods: We investigated 23 healthy male volunteers who were extensively clinically tested to exclude substance abuse. All of the subjects underwent 1 PET scan with the subtype-nonselective opioidergic radioligand 18F-fluoroethyl-diprenorphine under resting conditions without sensory or cognitive stimulation. Subsequently, the subjects were psychologically tested for the personality traits novelty seeking, harm avoidance, reward dependence, and persistence, according to Cloninger's biosocial model of personality. The binding potential (BP) as a parameter of regional cerebral opioid receptor availability was computed by means of the modified Logan plot using the occipital cortex as a reference region. Further imaging data analysis was performed using statistical parametric mapping; after stereotactic normalization, the correlations were calculated between the regional BP and the psychologic scores on a voxel-by-voxel basis. Results: The correlation analysis between personality dimensions and opioid receptor availability showed a significant (P < 0.001) positive correlation between the scores of reward dependence and the BP of the bilateral ventral striatum with nucleus accumbens (z scores, 4.52 and 4.33, respectively). The additionally performed region-of-interest–based correlation analysis yielded correlation coefficients of r = 0.84 and r = 0.81 for the left and right ventral striata, respectively. No further significant correlations were detectable between the other personality dimensions and cerebral opioid receptor binding. Conclusion: In healthy subjects, personality traits, which might be predisposing for addictive behavior, are correlated to the opioidergic neurotransmission in core structures of the human reward system.

Key Words: opioid receptor • personality • addiction • drug abuse • positron emission tomography

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  



This article has been cited by other articles:


Home page
J. Neurosci.Home page
P. Schweinhardt, D. A. Seminowicz, E. Jaeger, G. H. Duncan, and M. C. Bushnell
The Anatomy of the Mesolimbic Reward System: A Link between Personality and the Placebo Analgesic Response
J. Neurosci., April 15, 2009; 29(15): 4882 - 4887.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.